The results of many p38 studies appear to be contradictory: the lack of expression of expression of p38α or its upstream regulators MEK3 and MEK6 in a transgenic model led to a significant increase in heart size; whereas, negative expression of p38β led to a lack of cardiac hypertrophy but reduced systolic function [29], [30]. Here, MAPK11 is linked to cardiac hypertrophy.